FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/02/063212 [Registered on: 27/02/2024] Trial Registered Prospectively
Last Modified On: 20/02/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Other (Specify) [MOBILE APPLICATION BASED TOOL FOR COMPLIANCE]  
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   comparision of routine daily medicine intake vs mobile app based medicine intake to improve the adherence of advise given by the doctor 
Scientific Title of Study   Patient supported care model: Pilot study of a mobile application based tool to increase compliance in patients with chronic kidney disease 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Sanja Sameer Behera  
Designation  Senior Resident 
Affiliation  Post Graduate institute of Medical Education and Research, Chandigarh 
Address  Department of Nephrology PGIMER CHANDIGARH 160012

Chandigarh
CHANDIGARH
160012
India 
Phone  9168940405  
Fax    
Email  sanjasameer@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Vivek Kumar 
Designation  Associate Proffessor 
Affiliation  Post Graduate institute of Medical Education and Research, Chandigarh 
Address  Department of Nephrology PGIMER CHANDIGARH 160012

Chandigarh
CHANDIGARH
160012
India 
Phone  7087429731  
Fax    
Email  enigma165@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Sanja sameer Behera  
Designation  Senior Resident 
Affiliation  Post Graduate institute of Medical Education and Research, Chandigarh 
Address  Department of Nephrology PGIMER CHANDIGARH 160012

Chandigarh
CHANDIGARH
160012
India 
Phone  9168940405  
Fax    
Email  sanjasameer@gmail.com  
 
Source of Monetary or Material Support  
Post Graduate Institute of Medical education and Research, Chandigarh 
 
Primary Sponsor  
Name  Sanja Sameer Behera 
Address  senior resident, Department of Nephrology, PGIMER, Chandigarh, 160012 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
nil   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sanja Sameer Behera  PGIMER, Chandigarh  Room number-7,Department of Nephrology,C-Block, PGIMER,Chandigarh
Chandigarh
CHANDIGARH 
9168940405

sanjasameer@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
PGIMER Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N189||Chronic kidney disease, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Mobile Application based tool  Patients in intervention arm will be invited to install the mobile application on their smartphones and then, trained on how to use it. They will also be provided with instructional video for the same. The workflow will be as follows: Doctor prescribes drugs to the patient. The prescription slip is captured either electronically or as a photograph in application. The patient/hospital staff enters the actually delivered/procured drugs in application (note is made of drug name/dosage/administration schedule/quantity bought or delivered or procured for each drug). The patient now receives daily reminders as per previously captured schedule. A pop-up requests confirmation as to whether he has taken drugs or not within last 24 hours. If not, he selects which ones he has not taken. He can record the reason as text or voice message. There will also be a provision for patients to record any issues (related to mobile application or health status) that they might face through text or voice. In case of any emergency, they may contact the investigators through telephone or visit the hospital. Records of the same will be maintained by the investigators. Lack of input in the mobile application by patient for 24 hours will be taken as ‘missed one day of usage’. The patient gets reminder one week prior to estimated date of complete utilization of drug (based on data captured above). Patient goes back to doctor and the revised prescription is again captured as above. Information that will be captured through mobile application: 1. Prescription (type, dose, frequency, quantity) 2. Drugs taken (type, dose, frequency, quantity) 3. Compliance with prescription (number of times doses are missed) 4. Reasons for non-compliance 5. Any miscellaneous issues recorded by patient. They will also be instructed to bring prescription refill documents or bills mentioning the drugs and their delivered quantities and prices along with empty boxes/strips at the end of 3 months. 
Comparator Agent  Routine care  Patients in control arm will continue to receive care as they were receiving before. They will be instructed to bring prescription refill documents or bills mentioning the drugs and their delivered quantities and prices along with empty boxes/strips at the end of 3 months. They will also be encouraged to report causes for non-compliance with prescribed treatment, if any. All clinically significant events during the study period will be recorded.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  All patients with CKD stage G3-4 (defined as per KDIGO CKD guidelines) who will be attending the outpatient clinic in the Department of Nephrology at PGIMER with Clinically stable status for last 3 months as judged by treating physician and having Access to a smartphone that can run the mobile application
 
 
ExclusionCriteria 
Details  All patients with CKD stage G3-4 (defined as per KDIGO CKD guidelines) who will be attending the outpatient clinic in the Department of Nephrology at PGIMER with
1. Poor functional status as judged by treating physician
2. Present or past diagnosis of malignancy
3. Pregnancy or lactation in case of females
4. Organ transplant recipient
5. Previous diagnosis of any psychiatric illness or illicit drug abuse
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Primary Outcome
1. Difference in compliance (C) with prescribed treatment between groups

 
03 months 
 
Secondary Outcome  
Outcome  TimePoints 
1. Reasons for non-compliance in the study population
2. Proportion of patients who do not use mobile application for ≥15 days over 3 months in the intervention group and reasons for the same
 
03 months 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   01/03/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

A number of mobile applications are available which primarily serve to remind the patient about his prescribed medications. However, none of these is designed to ascertain the causes of non-compliance. We plan to use the basic workflow of such mobile applications and design a new mobile application with following features:

1.     Both the treating physician or supporting healthcare staff and patient will be users of the system.

2.     Patients will be able to enter the details of procured/bought/received medications in the application. These details will include name, dose and frequency. They will also note duration (in days) of the prescribed treatment.

3.     Physicians will be able to track the details of compliance and reasons for non-compliance, if recorded by the patient.

 
Close